NormanSLevyMD

Glaucoma Related

Professor Ophthalmology, University of Central Florida

Dr. Levy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
401 SW 88th Terrace
Gainesville, FL 32607
Phone+1 352-870-9200

Fax+1 352-332-4000

Professor of Ophthalmology College of Medicine, University of Central Florida (UCF), 2019-2020
SPIRIT OF Gainesville AWARD GAINESVILLE SUN PAPER, 2014
Paul Harris Fellow Rotary International, 2000
Paleologos Award Keratorefractive Society, 1995
Best Resident's Paper of the Chicago Ophthalmological Society Chicago Ophthalmological Society, 1970
Carl Wigger's Prize in Physiology Case-Western Reserve University, 1965
Fellow (FACS) American College of Surgeons
Fellow (FAAO) American Academy of Ophthalmology
Join now to see all

PubMed

1 citations
Importance of Accommodation and Eye Dominance for Measuring Objective Refractions.
Andrzej Grzybowski, Ronald A. Schachar, Barbara K. Pierscionek, Norman S. Levy, Ira H. Schachar
American Journal of Ophthalmology. 2017-06-01
2 citations
Axial length probably does not change with shift in gaze.
Ronald A. Schachar, Norman S. Levy
Investigative Ophthalmology & Visual Science. 2012-10-30
5 citations
Application of botulinum toxin to clinical therapy: advances and cautions.
Norman S. Levy, David T. Lowenthal
American Journal of Therapeutics. 2012-07-01

Journal Articles

Pupillary and Accomodative Abnormalities in the Vogt-Koyanagi-Harada Syndrome
Levy, N. S., Kramer, S. G., and Debarros, T.:, Am J Ophthalmol, 7/1970

Alternative Interpretation of the Age-Related Decrease in Circumlental Space.January 2006

DIRECTOR, FLORIDA OPHTHALMIC INSTITUTECLINICAL PHARMACEUTICAL RESEARCH FACILITY- The FOI has participated in sponsor designed FDA clinical trials from phase 1 through post approval, involving both medication and devices. Over 40 sponsored research studies were successfully completed from 1990 to the current date.1976 - 2020